Global GalNAc-siRNA Conjugates Market Growth 2026-2032
The global GalNAc-siRNA Conjugates market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
GalNAc-siRNA conjugates are polysaccharide-siRNA monojugates formed by covalently affixing N-acetylated galactosamine (GalNAc) to the 3' end of the right-hand strand of siRNAs of different sequences in a trivalent state. GalNAc is a targeting ligand for the sialic acid receptor (ASGPR), which has a high affinity for liver surface cells and rapid internalization, thus enabling this class of siRNA conjugates to specifically bind membrane proteins into the cytosol. GalNAc conjugated modifications are currently the most commonly used small nucleic acid drug delivery system and have excellent potential for use in the treatment of liver-related diseases involving gene overexpression. GalNAc conjugates have largely replaced lipid nanoparticle (LNP) delivery for siRNA delivery in liver-targeted diseases.
United States market for GalNAc-siRNA Conjugates is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GalNAc-siRNA Conjugates is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GalNAc-siRNA Conjugates is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GalNAc-siRNA Conjugates players cover WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “GalNAc-siRNA Conjugates Industry Forecast” looks at past sales and reviews total world GalNAc-siRNA Conjugates sales in 2025, providing a comprehensive analysis by region and market sector of projected GalNAc-siRNA Conjugates sales for 2026 through 2032. With GalNAc-siRNA Conjugates sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GalNAc-siRNA Conjugates industry.
This Insight Report provides a comprehensive analysis of the global GalNAc-siRNA Conjugates landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GalNAc-siRNA Conjugates portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GalNAc-siRNA Conjugates market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GalNAc-siRNA Conjugates and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GalNAc-siRNA Conjugates.
This report presents a comprehensive overview, market shares, and growth opportunities of GalNAc-siRNA Conjugates market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global GalNAc-siRNA Conjugates market?
What factors are driving GalNAc-siRNA Conjugates market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GalNAc-siRNA Conjugates market opportunities vary by end market size?
How does GalNAc-siRNA Conjugates break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
GalNAc-siRNA conjugates are polysaccharide-siRNA monojugates formed by covalently affixing N-acetylated galactosamine (GalNAc) to the 3' end of the right-hand strand of siRNAs of different sequences in a trivalent state. GalNAc is a targeting ligand for the sialic acid receptor (ASGPR), which has a high affinity for liver surface cells and rapid internalization, thus enabling this class of siRNA conjugates to specifically bind membrane proteins into the cytosol. GalNAc conjugated modifications are currently the most commonly used small nucleic acid drug delivery system and have excellent potential for use in the treatment of liver-related diseases involving gene overexpression. GalNAc conjugates have largely replaced lipid nanoparticle (LNP) delivery for siRNA delivery in liver-targeted diseases.
United States market for GalNAc-siRNA Conjugates is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GalNAc-siRNA Conjugates is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GalNAc-siRNA Conjugates is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GalNAc-siRNA Conjugates players cover WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “GalNAc-siRNA Conjugates Industry Forecast” looks at past sales and reviews total world GalNAc-siRNA Conjugates sales in 2025, providing a comprehensive analysis by region and market sector of projected GalNAc-siRNA Conjugates sales for 2026 through 2032. With GalNAc-siRNA Conjugates sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GalNAc-siRNA Conjugates industry.
This Insight Report provides a comprehensive analysis of the global GalNAc-siRNA Conjugates landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GalNAc-siRNA Conjugates portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GalNAc-siRNA Conjugates market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GalNAc-siRNA Conjugates and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GalNAc-siRNA Conjugates.
This report presents a comprehensive overview, market shares, and growth opportunities of GalNAc-siRNA Conjugates market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Mono-GalNAc-siRNA
- Di-GalNAc-siRNA
- Tri-GalNAc-siRNA
- Tetra-GalNAc-siRNA
- Liver Disorders
- Cancer
- Neurodegenerative Conditions
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- WuXi XDC
- BOCSCI Inc.
- Creative Biogene
- Creative Biolabs
- Bachem
- Biosynthesis
- LGC Biosearch Technologies
- Sinopep
- Organix
- CD Formulation
- Hitgen
What is the 10-year outlook for the global GalNAc-siRNA Conjugates market?
What factors are driving GalNAc-siRNA Conjugates market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GalNAc-siRNA Conjugates market opportunities vary by end market size?
How does GalNAc-siRNA Conjugates break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GalNAc-siRNA Conjugates Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GalNAc-siRNA Conjugates by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GalNAc-siRNA Conjugates by Country/Region, 2021, 2025 & 2032
2.2 GalNAc-siRNA Conjugates Segment by Type
2.2.1 Mono-GalNAc-siRNA
2.2.2 Di-GalNAc-siRNA
2.2.3 Tri-GalNAc-siRNA
2.2.4 Tetra-GalNAc-siRNA
2.2.5 GalNAc-siRNA Conjugates Sales by Type
2.2.5.1 Global GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
2.2.5.2 Global GalNAc-siRNA Conjugates Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global GalNAc-siRNA Conjugates Sale Price by Type (2021-2026)
2.3 GalNAc-siRNA Conjugates Segment by Application
2.3.1 Liver Disorders
2.3.2 Cancer
2.3.3 Neurodegenerative Conditions
2.3.4 Other
2.3.5 GalNAc-siRNA Conjugates Sales by Application
2.3.5.1 Global GalNAc-siRNA Conjugates Sale Market Share by Application (2021-2026)
2.3.5.2 Global GalNAc-siRNA Conjugates Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global GalNAc-siRNA Conjugates Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GalNAc-siRNA Conjugates Breakdown Data by Company
3.1.1 Global GalNAc-siRNA Conjugates Annual Sales by Company (2021-2026)
3.1.2 Global GalNAc-siRNA Conjugates Sales Market Share by Company (2021-2026)
3.2 Global GalNAc-siRNA Conjugates Annual Revenue by Company (2021-2026)
3.2.1 Global GalNAc-siRNA Conjugates Revenue by Company (2021-2026)
3.2.2 Global GalNAc-siRNA Conjugates Revenue Market Share by Company (2021-2026)
3.3 Global GalNAc-siRNA Conjugates Sale Price by Company
3.4 Key Manufacturers GalNAc-siRNA Conjugates Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GalNAc-siRNA Conjugates Product Location Distribution
3.4.2 Players GalNAc-siRNA Conjugates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GALNAC-SIRNA CONJUGATES BY GEOGRAPHIC REGION
4.1 World Historic GalNAc-siRNA Conjugates Market Size by Geographic Region (2021-2026)
4.1.1 Global GalNAc-siRNA Conjugates Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GalNAc-siRNA Conjugates Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GalNAc-siRNA Conjugates Market Size by Country/Region (2021-2026)
4.2.1 Global GalNAc-siRNA Conjugates Annual Sales by Country/Region (2021-2026)
4.2.2 Global GalNAc-siRNA Conjugates Annual Revenue by Country/Region (2021-2026)
4.3 Americas GalNAc-siRNA Conjugates Sales Growth
4.4 APAC GalNAc-siRNA Conjugates Sales Growth
4.5 Europe GalNAc-siRNA Conjugates Sales Growth
4.6 Middle East & Africa GalNAc-siRNA Conjugates Sales Growth
5 AMERICAS
5.1 Americas GalNAc-siRNA Conjugates Sales by Country
5.1.1 Americas GalNAc-siRNA Conjugates Sales by Country (2021-2026)
5.1.2 Americas GalNAc-siRNA Conjugates Revenue by Country (2021-2026)
5.2 Americas GalNAc-siRNA Conjugates Sales by Type (2021-2026)
5.3 Americas GalNAc-siRNA Conjugates Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GalNAc-siRNA Conjugates Sales by Region
6.1.1 APAC GalNAc-siRNA Conjugates Sales by Region (2021-2026)
6.1.2 APAC GalNAc-siRNA Conjugates Revenue by Region (2021-2026)
6.2 APAC GalNAc-siRNA Conjugates Sales by Type (2021-2026)
6.3 APAC GalNAc-siRNA Conjugates Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GalNAc-siRNA Conjugates by Country
7.1.1 Europe GalNAc-siRNA Conjugates Sales by Country (2021-2026)
7.1.2 Europe GalNAc-siRNA Conjugates Revenue by Country (2021-2026)
7.2 Europe GalNAc-siRNA Conjugates Sales by Type (2021-2026)
7.3 Europe GalNAc-siRNA Conjugates Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GalNAc-siRNA Conjugates by Country
8.1.1 Middle East & Africa GalNAc-siRNA Conjugates Sales by Country (2021-2026)
8.1.2 Middle East & Africa GalNAc-siRNA Conjugates Revenue by Country (2021-2026)
8.2 Middle East & Africa GalNAc-siRNA Conjugates Sales by Type (2021-2026)
8.3 Middle East & Africa GalNAc-siRNA Conjugates Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GalNAc-siRNA Conjugates
10.3 Manufacturing Process Analysis of GalNAc-siRNA Conjugates
10.4 Industry Chain Structure of GalNAc-siRNA Conjugates
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GalNAc-siRNA Conjugates Distributors
11.3 GalNAc-siRNA Conjugates Customer
12 WORLD FORECAST REVIEW FOR GALNAC-SIRNA CONJUGATES BY GEOGRAPHIC REGION
12.1 Global GalNAc-siRNA Conjugates Market Size Forecast by Region
12.1.1 Global GalNAc-siRNA Conjugates Forecast by Region (2027-2032)
12.1.2 Global GalNAc-siRNA Conjugates Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GalNAc-siRNA Conjugates Forecast by Type (2027-2032)
12.7 Global GalNAc-siRNA Conjugates Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 WuXi XDC
13.1.1 WuXi XDC Company Information
13.1.2 WuXi XDC GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.1.3 WuXi XDC GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 WuXi XDC Main Business Overview
13.1.5 WuXi XDC Latest Developments
13.2 BOCSCI Inc.
13.2.1 BOCSCI Inc. Company Information
13.2.2 BOCSCI Inc. GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.2.3 BOCSCI Inc. GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BOCSCI Inc. Main Business Overview
13.2.5 BOCSCI Inc. Latest Developments
13.3 Creative Biogene
13.3.1 Creative Biogene Company Information
13.3.2 Creative Biogene GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.3.3 Creative Biogene GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Creative Biogene Main Business Overview
13.3.5 Creative Biogene Latest Developments
13.4 Creative Biolabs
13.4.1 Creative Biolabs Company Information
13.4.2 Creative Biolabs GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.4.3 Creative Biolabs GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Creative Biolabs Main Business Overview
13.4.5 Creative Biolabs Latest Developments
13.5 Bachem
13.5.1 Bachem Company Information
13.5.2 Bachem GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.5.3 Bachem GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Bachem Main Business Overview
13.5.5 Bachem Latest Developments
13.6 Biosynthesis
13.6.1 Biosynthesis Company Information
13.6.2 Biosynthesis GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.6.3 Biosynthesis GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Biosynthesis Main Business Overview
13.6.5 Biosynthesis Latest Developments
13.7 LGC Biosearch Technologies
13.7.1 LGC Biosearch Technologies Company Information
13.7.2 LGC Biosearch Technologies GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.7.3 LGC Biosearch Technologies GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 LGC Biosearch Technologies Main Business Overview
13.7.5 LGC Biosearch Technologies Latest Developments
13.8 Sinopep
13.8.1 Sinopep Company Information
13.8.2 Sinopep GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.8.3 Sinopep GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinopep Main Business Overview
13.8.5 Sinopep Latest Developments
13.9 Organix
13.9.1 Organix Company Information
13.9.2 Organix GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.9.3 Organix GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Organix Main Business Overview
13.9.5 Organix Latest Developments
13.10 CD Formulation
13.10.1 CD Formulation Company Information
13.10.2 CD Formulation GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.10.3 CD Formulation GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CD Formulation Main Business Overview
13.10.5 CD Formulation Latest Developments
13.11 Hitgen
13.11.1 Hitgen Company Information
13.11.2 Hitgen GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.11.3 Hitgen GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hitgen Main Business Overview
13.11.5 Hitgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GalNAc-siRNA Conjugates Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GalNAc-siRNA Conjugates by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GalNAc-siRNA Conjugates by Country/Region, 2021, 2025 & 2032
2.2 GalNAc-siRNA Conjugates Segment by Type
2.2.1 Mono-GalNAc-siRNA
2.2.2 Di-GalNAc-siRNA
2.2.3 Tri-GalNAc-siRNA
2.2.4 Tetra-GalNAc-siRNA
2.2.5 GalNAc-siRNA Conjugates Sales by Type
2.2.5.1 Global GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
2.2.5.2 Global GalNAc-siRNA Conjugates Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global GalNAc-siRNA Conjugates Sale Price by Type (2021-2026)
2.3 GalNAc-siRNA Conjugates Segment by Application
2.3.1 Liver Disorders
2.3.2 Cancer
2.3.3 Neurodegenerative Conditions
2.3.4 Other
2.3.5 GalNAc-siRNA Conjugates Sales by Application
2.3.5.1 Global GalNAc-siRNA Conjugates Sale Market Share by Application (2021-2026)
2.3.5.2 Global GalNAc-siRNA Conjugates Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global GalNAc-siRNA Conjugates Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GalNAc-siRNA Conjugates Breakdown Data by Company
3.1.1 Global GalNAc-siRNA Conjugates Annual Sales by Company (2021-2026)
3.1.2 Global GalNAc-siRNA Conjugates Sales Market Share by Company (2021-2026)
3.2 Global GalNAc-siRNA Conjugates Annual Revenue by Company (2021-2026)
3.2.1 Global GalNAc-siRNA Conjugates Revenue by Company (2021-2026)
3.2.2 Global GalNAc-siRNA Conjugates Revenue Market Share by Company (2021-2026)
3.3 Global GalNAc-siRNA Conjugates Sale Price by Company
3.4 Key Manufacturers GalNAc-siRNA Conjugates Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GalNAc-siRNA Conjugates Product Location Distribution
3.4.2 Players GalNAc-siRNA Conjugates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GALNAC-SIRNA CONJUGATES BY GEOGRAPHIC REGION
4.1 World Historic GalNAc-siRNA Conjugates Market Size by Geographic Region (2021-2026)
4.1.1 Global GalNAc-siRNA Conjugates Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GalNAc-siRNA Conjugates Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GalNAc-siRNA Conjugates Market Size by Country/Region (2021-2026)
4.2.1 Global GalNAc-siRNA Conjugates Annual Sales by Country/Region (2021-2026)
4.2.2 Global GalNAc-siRNA Conjugates Annual Revenue by Country/Region (2021-2026)
4.3 Americas GalNAc-siRNA Conjugates Sales Growth
4.4 APAC GalNAc-siRNA Conjugates Sales Growth
4.5 Europe GalNAc-siRNA Conjugates Sales Growth
4.6 Middle East & Africa GalNAc-siRNA Conjugates Sales Growth
5 AMERICAS
5.1 Americas GalNAc-siRNA Conjugates Sales by Country
5.1.1 Americas GalNAc-siRNA Conjugates Sales by Country (2021-2026)
5.1.2 Americas GalNAc-siRNA Conjugates Revenue by Country (2021-2026)
5.2 Americas GalNAc-siRNA Conjugates Sales by Type (2021-2026)
5.3 Americas GalNAc-siRNA Conjugates Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GalNAc-siRNA Conjugates Sales by Region
6.1.1 APAC GalNAc-siRNA Conjugates Sales by Region (2021-2026)
6.1.2 APAC GalNAc-siRNA Conjugates Revenue by Region (2021-2026)
6.2 APAC GalNAc-siRNA Conjugates Sales by Type (2021-2026)
6.3 APAC GalNAc-siRNA Conjugates Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GalNAc-siRNA Conjugates by Country
7.1.1 Europe GalNAc-siRNA Conjugates Sales by Country (2021-2026)
7.1.2 Europe GalNAc-siRNA Conjugates Revenue by Country (2021-2026)
7.2 Europe GalNAc-siRNA Conjugates Sales by Type (2021-2026)
7.3 Europe GalNAc-siRNA Conjugates Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GalNAc-siRNA Conjugates by Country
8.1.1 Middle East & Africa GalNAc-siRNA Conjugates Sales by Country (2021-2026)
8.1.2 Middle East & Africa GalNAc-siRNA Conjugates Revenue by Country (2021-2026)
8.2 Middle East & Africa GalNAc-siRNA Conjugates Sales by Type (2021-2026)
8.3 Middle East & Africa GalNAc-siRNA Conjugates Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GalNAc-siRNA Conjugates
10.3 Manufacturing Process Analysis of GalNAc-siRNA Conjugates
10.4 Industry Chain Structure of GalNAc-siRNA Conjugates
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GalNAc-siRNA Conjugates Distributors
11.3 GalNAc-siRNA Conjugates Customer
12 WORLD FORECAST REVIEW FOR GALNAC-SIRNA CONJUGATES BY GEOGRAPHIC REGION
12.1 Global GalNAc-siRNA Conjugates Market Size Forecast by Region
12.1.1 Global GalNAc-siRNA Conjugates Forecast by Region (2027-2032)
12.1.2 Global GalNAc-siRNA Conjugates Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GalNAc-siRNA Conjugates Forecast by Type (2027-2032)
12.7 Global GalNAc-siRNA Conjugates Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 WuXi XDC
13.1.1 WuXi XDC Company Information
13.1.2 WuXi XDC GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.1.3 WuXi XDC GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 WuXi XDC Main Business Overview
13.1.5 WuXi XDC Latest Developments
13.2 BOCSCI Inc.
13.2.1 BOCSCI Inc. Company Information
13.2.2 BOCSCI Inc. GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.2.3 BOCSCI Inc. GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BOCSCI Inc. Main Business Overview
13.2.5 BOCSCI Inc. Latest Developments
13.3 Creative Biogene
13.3.1 Creative Biogene Company Information
13.3.2 Creative Biogene GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.3.3 Creative Biogene GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Creative Biogene Main Business Overview
13.3.5 Creative Biogene Latest Developments
13.4 Creative Biolabs
13.4.1 Creative Biolabs Company Information
13.4.2 Creative Biolabs GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.4.3 Creative Biolabs GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Creative Biolabs Main Business Overview
13.4.5 Creative Biolabs Latest Developments
13.5 Bachem
13.5.1 Bachem Company Information
13.5.2 Bachem GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.5.3 Bachem GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Bachem Main Business Overview
13.5.5 Bachem Latest Developments
13.6 Biosynthesis
13.6.1 Biosynthesis Company Information
13.6.2 Biosynthesis GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.6.3 Biosynthesis GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Biosynthesis Main Business Overview
13.6.5 Biosynthesis Latest Developments
13.7 LGC Biosearch Technologies
13.7.1 LGC Biosearch Technologies Company Information
13.7.2 LGC Biosearch Technologies GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.7.3 LGC Biosearch Technologies GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 LGC Biosearch Technologies Main Business Overview
13.7.5 LGC Biosearch Technologies Latest Developments
13.8 Sinopep
13.8.1 Sinopep Company Information
13.8.2 Sinopep GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.8.3 Sinopep GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinopep Main Business Overview
13.8.5 Sinopep Latest Developments
13.9 Organix
13.9.1 Organix Company Information
13.9.2 Organix GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.9.3 Organix GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Organix Main Business Overview
13.9.5 Organix Latest Developments
13.10 CD Formulation
13.10.1 CD Formulation Company Information
13.10.2 CD Formulation GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.10.3 CD Formulation GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CD Formulation Main Business Overview
13.10.5 CD Formulation Latest Developments
13.11 Hitgen
13.11.1 Hitgen Company Information
13.11.2 Hitgen GalNAc-siRNA Conjugates Product Portfolios and Specifications
13.11.3 Hitgen GalNAc-siRNA Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hitgen Main Business Overview
13.11.5 Hitgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GalNAc-siRNA Conjugates Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GalNAc-siRNA Conjugates Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Mono-GalNAc-siRNA
Table 4. Major Players of Di-GalNAc-siRNA
Table 5. Major Players of Tri-GalNAc-siRNA
Table 6. Major Players of Tetra-GalNAc-siRNA
Table 7. Global GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 8. Global GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Table 9. Global GalNAc-siRNA Conjugates Revenue by Type (2021-2026) & ($ million)
Table 10. Global GalNAc-siRNA Conjugates Revenue Market Share by Type (2021-2026)
Table 11. Global GalNAc-siRNA Conjugates Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global GalNAc-siRNA Conjugates Sale by Application (2021-2026) & (Kg)
Table 13. Global GalNAc-siRNA Conjugates Sale Market Share by Application (2021-2026)
Table 14. Global GalNAc-siRNA Conjugates Revenue by Application (2021-2026) & ($ million)
Table 15. Global GalNAc-siRNA Conjugates Revenue Market Share by Application (2021-2026)
Table 16. Global GalNAc-siRNA Conjugates Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global GalNAc-siRNA Conjugates Sales by Company (2021-2026) & (Kg)
Table 18. Global GalNAc-siRNA Conjugates Sales Market Share by Company (2021-2026)
Table 19. Global GalNAc-siRNA Conjugates Revenue by Company (2021-2026) & ($ millions)
Table 20. Global GalNAc-siRNA Conjugates Revenue Market Share by Company (2021-2026)
Table 21. Global GalNAc-siRNA Conjugates Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers GalNAc-siRNA Conjugates Producing Area Distribution and Sales Area
Table 23. Players GalNAc-siRNA Conjugates Products Offered
Table 24. GalNAc-siRNA Conjugates Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global GalNAc-siRNA Conjugates Sales by Geographic Region (2021-2026) & (Kg)
Table 28. Global GalNAc-siRNA Conjugates Sales Market Share Geographic Region (2021-2026)
Table 29. Global GalNAc-siRNA Conjugates Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global GalNAc-siRNA Conjugates Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global GalNAc-siRNA Conjugates Sales by Country/Region (2021-2026) & (Kg)
Table 32. Global GalNAc-siRNA Conjugates Sales Market Share by Country/Region (2021-2026)
Table 33. Global GalNAc-siRNA Conjugates Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global GalNAc-siRNA Conjugates Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas GalNAc-siRNA Conjugates Sales by Country (2021-2026) & (Kg)
Table 36. Americas GalNAc-siRNA Conjugates Sales Market Share by Country (2021-2026)
Table 37. Americas GalNAc-siRNA Conjugates Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 39. Americas GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 40. APAC GalNAc-siRNA Conjugates Sales by Region (2021-2026) & (Kg)
Table 41. APAC GalNAc-siRNA Conjugates Sales Market Share by Region (2021-2026)
Table 42. APAC GalNAc-siRNA Conjugates Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 44. APAC GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 45. Europe GalNAc-siRNA Conjugates Sales by Country (2021-2026) & (Kg)
Table 46. Europe GalNAc-siRNA Conjugates Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 48. Europe GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 49. Middle East & Africa GalNAc-siRNA Conjugates Sales by Country (2021-2026) & (Kg)
Table 50. Middle East & Africa GalNAc-siRNA Conjugates Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 52. Middle East & Africa GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 53. Key Market Drivers & Growth Opportunities of GalNAc-siRNA Conjugates
Table 54. Key Market Challenges & Risks of GalNAc-siRNA Conjugates
Table 55. Key Industry Trends of GalNAc-siRNA Conjugates
Table 56. GalNAc-siRNA Conjugates Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. GalNAc-siRNA Conjugates Distributors List
Table 59. GalNAc-siRNA Conjugates Customer List
Table 60. Global GalNAc-siRNA Conjugates Sales Forecast by Region (2027-2032) & (Kg)
Table 61. Global GalNAc-siRNA Conjugates Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas GalNAc-siRNA Conjugates Sales Forecast by Country (2027-2032) & (Kg)
Table 63. Americas GalNAc-siRNA Conjugates Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC GalNAc-siRNA Conjugates Sales Forecast by Region (2027-2032) & (Kg)
Table 65. APAC GalNAc-siRNA Conjugates Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe GalNAc-siRNA Conjugates Sales Forecast by Country (2027-2032) & (Kg)
Table 67. Europe GalNAc-siRNA Conjugates Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa GalNAc-siRNA Conjugates Sales Forecast by Country (2027-2032) & (Kg)
Table 69. Middle East & Africa GalNAc-siRNA Conjugates Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global GalNAc-siRNA Conjugates Sales Forecast by Type (2027-2032) & (Kg)
Table 71. Global GalNAc-siRNA Conjugates Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global GalNAc-siRNA Conjugates Sales Forecast by Application (2027-2032) & (Kg)
Table 73. Global GalNAc-siRNA Conjugates Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. WuXi XDC Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 75. WuXi XDC GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 76. WuXi XDC GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. WuXi XDC Main Business
Table 78. WuXi XDC Latest Developments
Table 79. BOCSCI Inc. Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 80. BOCSCI Inc. GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 81. BOCSCI Inc. GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. BOCSCI Inc. Main Business
Table 83. BOCSCI Inc. Latest Developments
Table 84. Creative Biogene Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 85. Creative Biogene GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 86. Creative Biogene GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Creative Biogene Main Business
Table 88. Creative Biogene Latest Developments
Table 89. Creative Biolabs Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 90. Creative Biolabs GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 91. Creative Biolabs GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. Creative Biolabs Main Business
Table 93. Creative Biolabs Latest Developments
Table 94. Bachem Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 95. Bachem GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 96. Bachem GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. Bachem Main Business
Table 98. Bachem Latest Developments
Table 99. Biosynthesis Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 100. Biosynthesis GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 101. Biosynthesis GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. Biosynthesis Main Business
Table 103. Biosynthesis Latest Developments
Table 104. LGC Biosearch Technologies Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 105. LGC Biosearch Technologies GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 106. LGC Biosearch Technologies GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. LGC Biosearch Technologies Main Business
Table 108. LGC Biosearch Technologies Latest Developments
Table 109. Sinopep Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 110. Sinopep GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 111. Sinopep GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Sinopep Main Business
Table 113. Sinopep Latest Developments
Table 114. Organix Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 115. Organix GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 116. Organix GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Organix Main Business
Table 118. Organix Latest Developments
Table 119. CD Formulation Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 120. CD Formulation GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 121. CD Formulation GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 122. CD Formulation Main Business
Table 123. CD Formulation Latest Developments
Table 124. Hitgen Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 125. Hitgen GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 126. Hitgen GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 127. Hitgen Main Business
Table 128. Hitgen Latest Developments
Table 1. GalNAc-siRNA Conjugates Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GalNAc-siRNA Conjugates Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Mono-GalNAc-siRNA
Table 4. Major Players of Di-GalNAc-siRNA
Table 5. Major Players of Tri-GalNAc-siRNA
Table 6. Major Players of Tetra-GalNAc-siRNA
Table 7. Global GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 8. Global GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Table 9. Global GalNAc-siRNA Conjugates Revenue by Type (2021-2026) & ($ million)
Table 10. Global GalNAc-siRNA Conjugates Revenue Market Share by Type (2021-2026)
Table 11. Global GalNAc-siRNA Conjugates Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global GalNAc-siRNA Conjugates Sale by Application (2021-2026) & (Kg)
Table 13. Global GalNAc-siRNA Conjugates Sale Market Share by Application (2021-2026)
Table 14. Global GalNAc-siRNA Conjugates Revenue by Application (2021-2026) & ($ million)
Table 15. Global GalNAc-siRNA Conjugates Revenue Market Share by Application (2021-2026)
Table 16. Global GalNAc-siRNA Conjugates Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global GalNAc-siRNA Conjugates Sales by Company (2021-2026) & (Kg)
Table 18. Global GalNAc-siRNA Conjugates Sales Market Share by Company (2021-2026)
Table 19. Global GalNAc-siRNA Conjugates Revenue by Company (2021-2026) & ($ millions)
Table 20. Global GalNAc-siRNA Conjugates Revenue Market Share by Company (2021-2026)
Table 21. Global GalNAc-siRNA Conjugates Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers GalNAc-siRNA Conjugates Producing Area Distribution and Sales Area
Table 23. Players GalNAc-siRNA Conjugates Products Offered
Table 24. GalNAc-siRNA Conjugates Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global GalNAc-siRNA Conjugates Sales by Geographic Region (2021-2026) & (Kg)
Table 28. Global GalNAc-siRNA Conjugates Sales Market Share Geographic Region (2021-2026)
Table 29. Global GalNAc-siRNA Conjugates Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global GalNAc-siRNA Conjugates Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global GalNAc-siRNA Conjugates Sales by Country/Region (2021-2026) & (Kg)
Table 32. Global GalNAc-siRNA Conjugates Sales Market Share by Country/Region (2021-2026)
Table 33. Global GalNAc-siRNA Conjugates Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global GalNAc-siRNA Conjugates Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas GalNAc-siRNA Conjugates Sales by Country (2021-2026) & (Kg)
Table 36. Americas GalNAc-siRNA Conjugates Sales Market Share by Country (2021-2026)
Table 37. Americas GalNAc-siRNA Conjugates Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 39. Americas GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 40. APAC GalNAc-siRNA Conjugates Sales by Region (2021-2026) & (Kg)
Table 41. APAC GalNAc-siRNA Conjugates Sales Market Share by Region (2021-2026)
Table 42. APAC GalNAc-siRNA Conjugates Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 44. APAC GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 45. Europe GalNAc-siRNA Conjugates Sales by Country (2021-2026) & (Kg)
Table 46. Europe GalNAc-siRNA Conjugates Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 48. Europe GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 49. Middle East & Africa GalNAc-siRNA Conjugates Sales by Country (2021-2026) & (Kg)
Table 50. Middle East & Africa GalNAc-siRNA Conjugates Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa GalNAc-siRNA Conjugates Sales by Type (2021-2026) & (Kg)
Table 52. Middle East & Africa GalNAc-siRNA Conjugates Sales by Application (2021-2026) & (Kg)
Table 53. Key Market Drivers & Growth Opportunities of GalNAc-siRNA Conjugates
Table 54. Key Market Challenges & Risks of GalNAc-siRNA Conjugates
Table 55. Key Industry Trends of GalNAc-siRNA Conjugates
Table 56. GalNAc-siRNA Conjugates Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. GalNAc-siRNA Conjugates Distributors List
Table 59. GalNAc-siRNA Conjugates Customer List
Table 60. Global GalNAc-siRNA Conjugates Sales Forecast by Region (2027-2032) & (Kg)
Table 61. Global GalNAc-siRNA Conjugates Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas GalNAc-siRNA Conjugates Sales Forecast by Country (2027-2032) & (Kg)
Table 63. Americas GalNAc-siRNA Conjugates Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC GalNAc-siRNA Conjugates Sales Forecast by Region (2027-2032) & (Kg)
Table 65. APAC GalNAc-siRNA Conjugates Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe GalNAc-siRNA Conjugates Sales Forecast by Country (2027-2032) & (Kg)
Table 67. Europe GalNAc-siRNA Conjugates Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa GalNAc-siRNA Conjugates Sales Forecast by Country (2027-2032) & (Kg)
Table 69. Middle East & Africa GalNAc-siRNA Conjugates Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global GalNAc-siRNA Conjugates Sales Forecast by Type (2027-2032) & (Kg)
Table 71. Global GalNAc-siRNA Conjugates Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global GalNAc-siRNA Conjugates Sales Forecast by Application (2027-2032) & (Kg)
Table 73. Global GalNAc-siRNA Conjugates Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. WuXi XDC Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 75. WuXi XDC GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 76. WuXi XDC GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. WuXi XDC Main Business
Table 78. WuXi XDC Latest Developments
Table 79. BOCSCI Inc. Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 80. BOCSCI Inc. GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 81. BOCSCI Inc. GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. BOCSCI Inc. Main Business
Table 83. BOCSCI Inc. Latest Developments
Table 84. Creative Biogene Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 85. Creative Biogene GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 86. Creative Biogene GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Creative Biogene Main Business
Table 88. Creative Biogene Latest Developments
Table 89. Creative Biolabs Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 90. Creative Biolabs GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 91. Creative Biolabs GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. Creative Biolabs Main Business
Table 93. Creative Biolabs Latest Developments
Table 94. Bachem Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 95. Bachem GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 96. Bachem GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. Bachem Main Business
Table 98. Bachem Latest Developments
Table 99. Biosynthesis Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 100. Biosynthesis GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 101. Biosynthesis GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. Biosynthesis Main Business
Table 103. Biosynthesis Latest Developments
Table 104. LGC Biosearch Technologies Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 105. LGC Biosearch Technologies GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 106. LGC Biosearch Technologies GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. LGC Biosearch Technologies Main Business
Table 108. LGC Biosearch Technologies Latest Developments
Table 109. Sinopep Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 110. Sinopep GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 111. Sinopep GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Sinopep Main Business
Table 113. Sinopep Latest Developments
Table 114. Organix Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 115. Organix GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 116. Organix GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Organix Main Business
Table 118. Organix Latest Developments
Table 119. CD Formulation Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 120. CD Formulation GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 121. CD Formulation GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 122. CD Formulation Main Business
Table 123. CD Formulation Latest Developments
Table 124. Hitgen Basic Information, GalNAc-siRNA Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 125. Hitgen GalNAc-siRNA Conjugates Product Portfolios and Specifications
Table 126. Hitgen GalNAc-siRNA Conjugates Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 127. Hitgen Main Business
Table 128. Hitgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of GalNAc-siRNA Conjugates
Figure 2. GalNAc-siRNA Conjugates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GalNAc-siRNA Conjugates Sales Growth Rate 2021-2032 (Kg)
Figure 7. Global GalNAc-siRNA Conjugates Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GalNAc-siRNA Conjugates Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GalNAc-siRNA Conjugates Sales Market Share by Country/Region (2025)
Figure 10. GalNAc-siRNA Conjugates Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Mono-GalNAc-siRNA
Figure 12. Product Picture of Di-GalNAc-siRNA
Figure 13. Product Picture of Tri-GalNAc-siRNA
Figure 14. Product Picture of Tetra-GalNAc-siRNA
Figure 15. Global GalNAc-siRNA Conjugates Sales Market Share by Type in 2026
Figure 16. Global GalNAc-siRNA Conjugates Revenue Market Share by Type (2021-2026)
Figure 17. GalNAc-siRNA Conjugates Consumed in Liver Disorders
Figure 18. Global GalNAc-siRNA Conjugates Market: Liver Disorders (2021-2026) & (Kg)
Figure 19. GalNAc-siRNA Conjugates Consumed in Cancer
Figure 20. Global GalNAc-siRNA Conjugates Market: Cancer (2021-2026) & (Kg)
Figure 21. GalNAc-siRNA Conjugates Consumed in Neurodegenerative Conditions
Figure 22. Global GalNAc-siRNA Conjugates Market: Neurodegenerative Conditions (2021-2026) & (Kg)
Figure 23. GalNAc-siRNA Conjugates Consumed in Other
Figure 24. Global GalNAc-siRNA Conjugates Market: Other (2021-2026) & (Kg)
Figure 25. Global GalNAc-siRNA Conjugates Sale Market Share by Application (2025)
Figure 26. Global GalNAc-siRNA Conjugates Revenue Market Share by Application in 2026
Figure 27. GalNAc-siRNA Conjugates Sales by Company in 2026 (Kg)
Figure 28. Global GalNAc-siRNA Conjugates Sales Market Share by Company in 2026
Figure 29. GalNAc-siRNA Conjugates Revenue by Company in 2026 ($ millions)
Figure 30. Global GalNAc-siRNA Conjugates Revenue Market Share by Company in 2026
Figure 31. Global GalNAc-siRNA Conjugates Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global GalNAc-siRNA Conjugates Revenue Market Share by Geographic Region in 2026
Figure 33. Americas GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 34. Americas GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 35. APAC GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 36. APAC GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 37. Europe GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 38. Europe GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 40. Middle East & Africa GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 41. Americas GalNAc-siRNA Conjugates Sales Market Share by Country in 2026
Figure 42. Americas GalNAc-siRNA Conjugates Revenue Market Share by Country (2021-2026)
Figure 43. Americas GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 44. Americas GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 45. United States GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC GalNAc-siRNA Conjugates Sales Market Share by Region in 2026
Figure 50. APAC GalNAc-siRNA Conjugates Revenue Market Share by Region (2021-2026)
Figure 51. APAC GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 52. APAC GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 53. China GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 57. India GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe GalNAc-siRNA Conjugates Sales Market Share by Country in 2026
Figure 61. Europe GalNAc-siRNA Conjugates Revenue Market Share by Country (2021-2026)
Figure 62. Europe GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 63. Europe GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 64. Germany GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 65. France GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 66. UK GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa GalNAc-siRNA Conjugates Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 72. Egypt GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of GalNAc-siRNA Conjugates in 2026
Figure 78. Manufacturing Process Analysis of GalNAc-siRNA Conjugates
Figure 79. Industry Chain Structure of GalNAc-siRNA Conjugates
Figure 80. Channels of Distribution
Figure 81. Global GalNAc-siRNA Conjugates Sales Market Forecast by Region (2027-2032)
Figure 82. Global GalNAc-siRNA Conjugates Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global GalNAc-siRNA Conjugates Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global GalNAc-siRNA Conjugates Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global GalNAc-siRNA Conjugates Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global GalNAc-siRNA Conjugates Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of GalNAc-siRNA Conjugates
Figure 2. GalNAc-siRNA Conjugates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GalNAc-siRNA Conjugates Sales Growth Rate 2021-2032 (Kg)
Figure 7. Global GalNAc-siRNA Conjugates Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GalNAc-siRNA Conjugates Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GalNAc-siRNA Conjugates Sales Market Share by Country/Region (2025)
Figure 10. GalNAc-siRNA Conjugates Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Mono-GalNAc-siRNA
Figure 12. Product Picture of Di-GalNAc-siRNA
Figure 13. Product Picture of Tri-GalNAc-siRNA
Figure 14. Product Picture of Tetra-GalNAc-siRNA
Figure 15. Global GalNAc-siRNA Conjugates Sales Market Share by Type in 2026
Figure 16. Global GalNAc-siRNA Conjugates Revenue Market Share by Type (2021-2026)
Figure 17. GalNAc-siRNA Conjugates Consumed in Liver Disorders
Figure 18. Global GalNAc-siRNA Conjugates Market: Liver Disorders (2021-2026) & (Kg)
Figure 19. GalNAc-siRNA Conjugates Consumed in Cancer
Figure 20. Global GalNAc-siRNA Conjugates Market: Cancer (2021-2026) & (Kg)
Figure 21. GalNAc-siRNA Conjugates Consumed in Neurodegenerative Conditions
Figure 22. Global GalNAc-siRNA Conjugates Market: Neurodegenerative Conditions (2021-2026) & (Kg)
Figure 23. GalNAc-siRNA Conjugates Consumed in Other
Figure 24. Global GalNAc-siRNA Conjugates Market: Other (2021-2026) & (Kg)
Figure 25. Global GalNAc-siRNA Conjugates Sale Market Share by Application (2025)
Figure 26. Global GalNAc-siRNA Conjugates Revenue Market Share by Application in 2026
Figure 27. GalNAc-siRNA Conjugates Sales by Company in 2026 (Kg)
Figure 28. Global GalNAc-siRNA Conjugates Sales Market Share by Company in 2026
Figure 29. GalNAc-siRNA Conjugates Revenue by Company in 2026 ($ millions)
Figure 30. Global GalNAc-siRNA Conjugates Revenue Market Share by Company in 2026
Figure 31. Global GalNAc-siRNA Conjugates Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global GalNAc-siRNA Conjugates Revenue Market Share by Geographic Region in 2026
Figure 33. Americas GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 34. Americas GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 35. APAC GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 36. APAC GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 37. Europe GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 38. Europe GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa GalNAc-siRNA Conjugates Sales 2021-2026 (Kg)
Figure 40. Middle East & Africa GalNAc-siRNA Conjugates Revenue 2021-2026 ($ millions)
Figure 41. Americas GalNAc-siRNA Conjugates Sales Market Share by Country in 2026
Figure 42. Americas GalNAc-siRNA Conjugates Revenue Market Share by Country (2021-2026)
Figure 43. Americas GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 44. Americas GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 45. United States GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC GalNAc-siRNA Conjugates Sales Market Share by Region in 2026
Figure 50. APAC GalNAc-siRNA Conjugates Revenue Market Share by Region (2021-2026)
Figure 51. APAC GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 52. APAC GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 53. China GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 57. India GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe GalNAc-siRNA Conjugates Sales Market Share by Country in 2026
Figure 61. Europe GalNAc-siRNA Conjugates Revenue Market Share by Country (2021-2026)
Figure 62. Europe GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 63. Europe GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 64. Germany GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 65. France GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 66. UK GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa GalNAc-siRNA Conjugates Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa GalNAc-siRNA Conjugates Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa GalNAc-siRNA Conjugates Sales Market Share by Application (2021-2026)
Figure 72. Egypt GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries GalNAc-siRNA Conjugates Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of GalNAc-siRNA Conjugates in 2026
Figure 78. Manufacturing Process Analysis of GalNAc-siRNA Conjugates
Figure 79. Industry Chain Structure of GalNAc-siRNA Conjugates
Figure 80. Channels of Distribution
Figure 81. Global GalNAc-siRNA Conjugates Sales Market Forecast by Region (2027-2032)
Figure 82. Global GalNAc-siRNA Conjugates Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global GalNAc-siRNA Conjugates Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global GalNAc-siRNA Conjugates Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global GalNAc-siRNA Conjugates Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global GalNAc-siRNA Conjugates Revenue Market Share Forecast by Application (2027-2032)
